A groundbreaking international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using ...

Exact Science’s Michelle Beidelschies, PhD, reveals how a multi-biomarker class multi-cancer early detection test (MCED) blood test can help health systems expand detection across more cancers earlier ...

A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique ...

A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...

The European voice/vocal biomarker market is positioned for substantial growth, reaching $1.69 billion by 2035 from $335.2 million in 2024, at a CAGR of 16%. Utilized for non-invasive health ...

IPF is a life-threatening lung disease with no known cause. Over time, the lungs become scarred, making it harder to breathe. More than 250,000 Americans are living with IPF and other interstitial ...

Blood-based Biomarker for Alzheimer’s Disease Market to reach US$ 554.2 Mn by 2035 at 14.3% CAGR, driven by demand for ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

Serum DKK1 measured at diagnosis correlated with AAV activity and identified patients at higher risk of end stage kidney ...